Sarcoidosis decisions — 2025

The Board granted service connection for sarcoidosis of the lungs and skin but denied service connection for a low back disability.

The Board denied an earlier effective date for the grant of service connection for nephropathy, and remanded several other claims including those for a vitamin deficiency, right inguinal hernia, and sarcoidosis due to insufficient evidence.

The Board granted service connection for emphysema and sarcoidosis, assigned an earlier effective date of August 10, 2022 for allergic rhinitis, and granted a higher initial rating of 10 percent for hypertension.

The Board denied earlier effective dates for the awards of service connection for sarcoidosis and ulcerative colitis.

The appeal was dismissed due to the Veteran's death while it was pending.

The Board denied the Veteran's appeal for a disability rating greater than 60 percent for obstructive sleep apnea, to include asthma and sarcoidosis.

The appeal regarding service connection for sarcoidosis was dismissed due to a procedural defect in the form used to file the appeal.

The Board remands the claims for service connection for a back disability and sarcoidosis due to insufficient evidence and need for additional development.

The Board denied service connection for a respiratory cancer of any type, lymphoma, and sarcoidosis as the evidence did not demonstrate current diagnoses or a nexus to active duty.

The Board remands the matter to correct a duty to assist error that occurred prior to the August 2024 rating decision on appeal, specifically to determine whether the current liver disorder is secondary to the service-connected diabetes mellitus.

The Board remands all claims for service connection due to a duty to assist error and the need to verify toxic exposure at Fort McClellan.

The claim for service connection for sarcoidosis was dismissed as the benefit sought has been granted in full. The Board remanded the initial compensable rating for migraines for further development.

The Board granted service connection for a lung condition, to include pulmonary vasculature-lungs, sarcoidosis of lung with sarcoidosis of lymph nodes, mild obstructive lung disease, and multiple pulmonary masses/nodules with bilateral hilar and mediastinal lymphadenopathy.

The Board granted a 100 percent evaluation for pulmonary sarcoidosis, denied an increased evaluation for anxiety and lumbar spine disability with radiculopathy.

The Board granted a rating of 60 percent for interstitial lung disease, both prior to and from November 10, 2022.

The Board remands the case to correct pre-decisional duty to assist errors, specifically to obtain a VA examination for the Veteran's sarcoidosis and an explanation regarding how the symptoms of sarcoidosis do or do not constitute pyramiding with OSA.

The Board denied an increased rating for sarcoidosis but remanded the decision on TDIU based on a single service-connected disability.

The Board remands the claim for service connection for sarcoidosis to correct duty to assist errors, including obtaining an Individual Longitudinal Exposure Record and addendum medical opinion.

The veteran's claim for service connection for eczema was granted, but the claim for a higher rating for sarcoidosis with asthma prior to July 8, 2019 was denied.

The veteran's claim for a higher rating for sarcoidosis was denied. The veteran was granted a 10 percent rating for hypertension and an earlier effective date of May 15, 2018, for service connection. The veteran's claim for a higher rating for chronic kidney disease was denied, but an earlier effective date of May 15, 2018, for service connection was granted. The veteran's claim for a compensable rating for erectile dysfunction (ED) was denied, but an earlier effective date of May 15, 2018, for service connection was granted. Several issues were remanded.